Advertisement
U.S. Markets closed

Bolt Biotherapeutics, Inc. (BOLT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
0.6264-0.0116 (-1.82%)
At close: 04:00PM EDT
0.6165 -0.01 (-1.58%)
After hours: 04:06PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 23.97M
Enterprise Value -30.84M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.13
Price/Book (mrq)0.28
Enterprise Value/Revenue -18.31
Enterprise Value/EBITDA 0.93

Trading Information

Stock Price History

Beta (5Y Monthly) 0.93
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.5600
52 Week Low 30.5450
50-Day Moving Average 30.6518
200-Day Moving Average 30.9172

Share Statistics

Avg Vol (3 month) 3169.35k
Avg Vol (10 day) 398.28k
Shares Outstanding 538.26M
Implied Shares Outstanding 6N/A
Float 825.04M
% Held by Insiders 13.46%
% Held by Institutions 159.93%
Shares Short (Sep 30, 2024) 4119.13k
Short Ratio (Sep 30, 2024) 40.65
Short % of Float (Sep 30, 2024) 40.39%
Short % of Shares Outstanding (Sep 30, 2024) 40.31%
Shares Short (prior month Aug 30, 2024) 4228.03k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,492.71%

Management Effectiveness

Return on Assets (ttm)-29.41%
Return on Equity (ttm)-58.04%

Income Statement

Revenue (ttm)11.17M
Revenue Per Share (ttm)0.29
Quarterly Revenue Growth (yoy)-11.00%
Gross Profit (ttm)N/A
EBITDA -72.23M
Net Income Avi to Common (ttm)-66.17M
Diluted EPS (ttm)-1.7400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)73.7M
Total Cash Per Share (mrq)1.93
Total Debt (mrq)18.89M
Total Debt/Equity (mrq)22.00
Current Ratio (mrq)4.28
Book Value Per Share (mrq)2.24

Cash Flow Statement

Operating Cash Flow (ttm)-63.91M
Levered Free Cash Flow (ttm)-33.36M